title: A review of antisense therapeutic interventions for molecular biological targets in asthma.
abstract: Modern tools of genomics and proteomics reveal potential therapeutic antisense targets in asthma, increasing the interest in the development of anti-mRNA drugs. In allergic asthma experimental models, antisense oligonucleotides (ASO) are administered by inhalation or systemically. ASO can be used for a large number of molecular targets: cell membrane receptors (G-protein coupled receptors, cytokine and chemokine receptors), membrane proteins, ion channels, cytokines and related factors, signaling non-receptor protein kinases (tyrosine kinases, and serine/threonine kinases) and regulators of transcription belonging to Cys4 zinc finger of nuclear receptor type or beta-scaffold factors with minor groove contacts classes/superclasses of transcription factors. A respirable ASO against the adenosine A(1) receptor was investigated in human trials. RNase P-associated external guide sequence (EGS) delivered into pulmonary tissues represents a potentially new therapeutic approach in asthma as well as ribozyme strategies. Small interfering RNA (siRNA) targeting key molecules involved in the patho-physiology of allergic asthma are expected to be of benefit as RNAi immunotherapy. Antagomirs, synthetic analogs of microRNA (miRNA), have important roles in regulation of gene expression in asthma. RNA interference (RNAi) technologies offer higher efficiency in suppressing the expression of specific genes, compared with traditional antisense approaches.
authors.affiliation: Department of Allergology, University of Medicine and Pharmacy, "Carol Davila", Bucharest, Romania.
authors.forename: Florin-Dan
authors.initials: FD
authors.lastname: Popescu
authors.forename: Florica
authors.initials: F
authors.lastname: Popescu
references.citation: Nature. 2004 Sep 16;431(7006):338-42
references.pmid: 15372040
references.citation: J Biol Chem. 2003 Feb 14;278(7):4725-9
references.pmid: 12493770
references.citation: J Biomed Biotechnol. 2006;2006(4):63675
references.pmid: 17057365
references.citation: Oligonucleotides. 2005 Summer;15(2):132-8
references.pmid: 15989427
references.citation: Am J Pharmacogenomics. 2003;3(2):97-106
references.pmid: 12749727
references.citation: Am J Respir Crit Care Med. 2001 Mar;163(4):989-93
references.pmid: 11282778
references.citation: J Clin Pharmacol. 1999 Jan;39(1):47-54
references.pmid: 9987700
references.citation: BioDrugs. 2006;20(1):1-11
references.pmid: 16573347
references.citation: Curr Drug Targets. 2003 Nov;4(8):619-23
references.pmid: 14577652
references.citation: J Immunol. 2005 Aug 1;175(3):1867-75
references.pmid: 16034130
references.citation: FEBS Lett. 2002 Sep 11;527(1-3):274-8
references.pmid: 12220673
references.citation: J Cell Biochem. 2006 May 1;98(1):14-35
references.pmid: 16440307
references.citation: Proc Natl Acad Sci U S A. 2006 Jan 3;103(1):153-8
references.pmid: 16371463
references.citation: Nanomedicine (Lond). 2007 Apr;2(2):169-81
references.pmid: 17716119
references.citation: Blood. 2007 May 15;109(10):4399-405
references.pmid: 17284533
references.citation: Eur J Biochem. 2003 Apr;270(8):1628-44
references.pmid: 12694176
references.citation: FEBS Lett. 2005 Jan 3;579(1):173-8
references.pmid: 15620709
references.citation: Cell Cycle. 2007 Feb 15;6(4):444-9
references.pmid: 17312397
references.citation: Int J Mol Med. 2005 Mar;15(3):391-9
references.pmid: 15702227
references.citation: Nature. 2004 Nov 11;432(7014):173-8
references.pmid: 15538359
references.citation: Blood. 2000 Feb 15;95(4):1249-57
references.pmid: 10666197
references.citation: Nat Biotechnol. 2004 Dec;22(12):1579-82
references.pmid: 15558046
references.citation: Chest. 2003 Mar;123(3 Suppl):363S-8S
references.pmid: 12628976
references.citation: Am J Respir Crit Care Med. 2005 Mar 15;171(6):571-8
references.pmid: 15557129
references.citation: Nat Rev Immunol. 2004 Apr;4(4):249-58
references.pmid: 15057783
references.citation: IDrugs. 2001 Jun;4(6):646-9
references.pmid: 16001306
references.citation: Nature. 2005 Dec 1;438(7068):685-9
references.pmid: 16258535
references.citation: Respir Res. 2001;2(1):5-9
references.pmid: 11686859
references.citation: J Exp Med. 1998 Aug 3;188(3):421-9
references.pmid: 9687520
references.citation: Histochem Cell Biol. 2006 Oct;126(4):495-505
references.pmid: 16708245
references.citation: J Biol Chem. 1995 Feb 10;270(6):2620-7
references.pmid: 7852327
references.citation: J Exp Med. 2001 Jun 4;193(11):1247-60
references.pmid: 11390432
references.citation: Int Immunopharmacol. 2004 Aug;4(8):1015-27
references.pmid: 15222976
references.citation: Am J Respir Cell Mol Biol. 2007 Jan;36(1):8-12
references.pmid: 16917074
references.citation: Springer Semin Immunopathol. 2004 Feb;25(3-4):281-94
references.pmid: 15007632
references.citation: J Cell Mol Med. 2005 Oct-Dec;9(4):840-53
references.pmid: 16364194
references.citation: Cancer Gene Ther. 2005 Oct;12(10):787-95
references.pmid: 15891770
references.citation: J Immunol. 2000 May 15;164(10):5409-15
references.pmid: 10799906
references.citation: Am J Respir Cell Mol Biol. 1999 Dec;21(6):728-37
references.pmid: 10572070
references.citation: J Immunol. 2002 Feb 15;168(4):1978-83
references.pmid: 11823534
references.citation: Acta Pharmacol Sin. 2005 Jul;26(7):780-8
references.pmid: 15960883
references.citation: Curr Pharm Des. 2006;12(25):3293-304
references.pmid: 17020535
references.citation: Am J Respir Crit Care Med. 2002 Apr 1;165(7):1015-21
references.pmid: 11934731
references.citation: Am J Respir Crit Care Med. 2004 Mar 1;169(5):596-603
references.pmid: 14670803
references.citation: Biochem Biophys Res Commun. 2006 Dec 15;351(2):431-7
references.pmid: 17070777
references.citation: Clin Rev Allergy Immunol. 2004 Dec;27(3):207-17
references.pmid: 15630157
references.citation: Nature. 2004 Sep 9;431(7005):211-7
references.pmid: 15311210
references.citation: Expert Opin Drug Deliv. 2005 Jan;2(1):3-28
references.pmid: 16296732
references.citation: Nature. 2006 May 4;441(7089):111-4
references.pmid: 16565705
references.citation: Adv Cancer Res. 2007;96:103-43
references.pmid: 17161678
references.citation: Pharmacol Rev. 2006 Jun;58(2):259-79
references.pmid: 16714488
references.citation: Clin Exp Pharmacol Physiol. 2006 May-Jun;33(5-6):533-40
references.pmid: 16700890
references.citation: Oligonucleotides. 2003;13(5):353-63
references.pmid: 15000826
references.citation: J Allergy Clin Immunol. 1999 Jul;104(1):205-14
references.pmid: 10400863
references.citation: Ann N Y Acad Sci. 2006 Oct;1082:62-73
references.pmid: 17145927
references.citation: Nat Rev Genet. 2007 Mar;8(3):173-84
references.pmid: 17304245
references.citation: Nucleic Acids Res. 2006 May 11;34(8):2294-304
references.pmid: 16690972
references.citation: N Engl J Med. 2006 Aug 31;355(9):953-4
references.pmid: 16943409
references.citation: Curr Opin Mol Ther. 2002 Oct;4(5):419-22
references.pmid: 12435042
references.citation: Ann N Y Acad Sci. 2006 Oct;1082:18-26
references.pmid: 17145920
references.citation: Allergy. 2007 Feb;62(2):102-12
references.pmid: 17298416
references.citation: Curr Opin Allergy Clin Immunol. 2002 Dec;2(6):533-6
references.pmid: 14752337
references.citation: Nature. 1998 Feb 19;391(6669):806-11
references.pmid: 9486653
references.citation: J Pharmacol Exp Ther. 2005 Sep;314(3):972-9
references.pmid: 15919763
references.citation: J Allergy Clin Immunol. 2004 Aug;114(2):288-95
references.pmid: 15316505
references.citation: Mutat Res. 2004 Sep;567(1):71-84
references.pmid: 15341903
references.citation: J Mol Histol. 2004 Aug;35(6):545-53
references.pmid: 15614608
references.citation: J Cell Mol Med. 2003 Oct-Dec;7(4):475-86
references.pmid: 14754517
references.citation: Curr Opin Investig Drugs. 2003 May;4(5):552-5
references.pmid: 12833648
references.citation: Ann N Y Acad Sci. 2006 Oct;1082:91-102
references.pmid: 17145930
references.citation: Am J Respir Cell Mol Biol. 2001 Feb;24(2):116-22
references.pmid: 11159044
references.citation: Nat Biotechnol. 2003 Dec;21(12):1457-65
references.pmid: 14647331
references.citation: Int Immunopharmacol. 2004 Dec 20;4(14):1817-28
references.pmid: 15531297
references.citation: J Allergy Clin Immunol. 2001 Feb;107(2):279-86
references.pmid: 11174194
references.citation: Mol Ther. 2006 Oct;14(4):463-70
references.pmid: 16877044
references.citation: J Biol Chem. 2000 Feb 18;275(7):4647-53
references.pmid: 10671493
references.citation: Curr Drug Targets Inflamm Allergy. 2005 Apr;4(2):267-70
references.pmid: 15853749
references.citation: J Pharmacol Exp Ther. 2007 Jun;321(3):938-46
references.pmid: 17389243
references.citation: J Immunol. 2002 Jul 15;169(2):1028-36
references.pmid: 12097411
references.citation: Expert Opin Ther Targets. 2005 Oct;9(5):901-21
references.pmid: 16185147
references.citation: Nat Biotechnol. 2004 Dec;22(12):1533-7
references.pmid: 15583662
references.citation: Curr Drug Targets. 2004 Jul;5(5):419-30
references.pmid: 15216908
references.citation: Science. 1994 Mar 4;263(5151):1269-73
references.pmid: 8122108
references.citation: Int J Mol Med. 2004 Jul;14(1):3-22
references.pmid: 15202012
references.citation: Histol Histopathol. 2007 Feb;22(2):211-7
references.pmid: 17149694
references.citation: J Exp Med. 2005 Jun 20;201(12):1875-9
references.pmid: 15967818
references.citation: Curr Allergy Asthma Rep. 2003 Jan;3(1):70-8
references.pmid: 12542998
references.citation: J Immunol. 2000 Apr 1;164(7):3790-7
references.pmid: 10725739
references.citation: Rev Med Suisse. 2007 Jan 17;3(94):103-6
references.pmid: 17354533
references.citation: Ann Allergy Asthma Immunol. 2006 Nov;97(5):567-76; quiz 576-8, 602
references.pmid: 17165262
references.citation: J Mol Biol. 2003 Apr 4;327(4):761-6
references.pmid: 12654261
references.citation: Antisense Nucleic Acid Drug Dev. 2002 Jun;12(3):177-81
references.pmid: 12162700
references.citation: Allergy. 2007 Feb;62(2):95-101
references.pmid: 17298415
references.citation: Semin Hematol. 1999 Oct;36(4 Suppl 6):9-14
references.pmid: 10530711
references.citation: Proc Natl Acad Sci U S A. 2001 Apr 24;98(9):5175-80
references.pmid: 11296262
references.citation: Antisense Nucleic Acid Drug Dev. 1999 Feb;9(1):71-80
references.pmid: 10192291
references.citation: Nature. 2006 May 25;441(7092):537-41
references.pmid: 16724069
references.citation: Oligonucleotides. 2006 Fall;16(3):239-52
references.pmid: 16978087
references.citation: J Mol Biol. 2004 Sep 24;342(4):1077-83
references.pmid: 15351636